Literature DB >> 28752210

Helicobacter pylori infection and atherosclerosis: is there a causal relationship?

Z Xu1,2, J Li2, H Wang3, G Xu4,5.   

Abstract

For many years, the coexistence of Helicobacter pylori (H. pylori) infection and atherosclerotic diseases in a disproportional number of patients has inspired the presumption that a causal relationship exists between the conditions. This presumption was evidenced by the simultaneously declining epidemics of duodenal ulcer and coronary artery diseases in the United States in the past 40 years, and was further evidenced by the detection of H. pylori and their DNA in atherosclerotic plaques. Suggested mechanisms underlying this possible causality include intensified inflammatory stress, dyslipidemia, abnormal glucose metabolism, arterial stiffness, increased blood pressure and malnutrition. However, a causal relationship was disproved by results from other studies, which indicated that common risk factors shared by H. pylori infection and atherosclerosis, such as aging, cigarette smoking, disadvantageous socioeconomic status and high salt intake, may predestine their coexistence. Understanding the nature of the relationship between H. pylori infection and atherosclerosis is of vital importance, because a causality may indicate a possible strategy for preventing and treating atherosclerosis by eradicating H. pylori infection in selected individuals. This review assessed current evidence for and against a causal relationship between H. pylori infection and atherosclerosis.

Entities:  

Mesh:

Year:  2017        PMID: 28752210     DOI: 10.1007/s10096-017-3054-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  101 in total

1.  Hemoglobin and atherosclerosis in patients with manifest arterial disease. The SMART-study.

Authors:  J M Dijk; G Wangge; Y van der Graaf; M L Bots; D E Grobbee; A Algra
Journal:  Atherosclerosis       Date:  2006-01-04       Impact factor: 5.162

2.  Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.

Authors:  Jia Qing Huang; Subbaramiah Sridhar; Richard H Hunt
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

3.  Association between infectious burden, socioeconomic status, and ischemic stroke.

Authors:  Frederick Palm; Pirkko J Pussinen; Annette Aigner; Heiko Becher; Florian Buggle; Matthias F Bauer; Caspar Grond-Ginsbach; Anton Safer; Christian Urbanek; Armin J Grau
Journal:  Atherosclerosis       Date:  2016-10-05       Impact factor: 5.162

4.  Detection of Helicobacter pylori in human carotid atherosclerotic plaques.

Authors:  S F Ameriso; E A Fridman; R C Leiguarda; G E Sevlever
Journal:  Stroke       Date:  2001-02       Impact factor: 7.914

5.  Proinflammatory state and circulating erythropoietin in persons with and without anemia.

Authors:  Luigi Ferrucci; Jack M Guralnik; Richard C Woodman; Stefania Bandinelli; Fulvio Lauretani; Anna Maria Corsi; Paulo H M Chaves; William B Ershler; Dan L Longo
Journal:  Am J Med       Date:  2005-11       Impact factor: 4.965

6.  Involvement of Helicobacter pylori infection and impaired glucose metabolism in the increase of brachial-ankle pulse wave velocity.

Authors:  Hiroyuki Yoshikawa; Kayo Aida; Atsuyoshi Mori; Shigeki Muto; Takanori Fukuda
Journal:  Helicobacter       Date:  2007-10       Impact factor: 5.753

7.  Aetiology of peptic ulcer: a prospective population study in Norway.

Authors:  R Johnsen; O H Førde; B Straume; P G Burhol
Journal:  J Epidemiol Community Health       Date:  1994-04       Impact factor: 3.710

8.  Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro.

Authors:  S E Crowe; L Alvarez; M Dytoc; R H Hunt; M Muller; P Sherman; J Patel; Y Jin; P B Ernst
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

9.  Detection of cytomegalovirus and Helicobacter pylori DNA in arterial walls with grade III atherosclerosis by PCR.

Authors:  Abdullah Kilic; Onder Onguru; Harun Tugcu; Selim Kilic; Cakir Guney; Yasar Bilge
Journal:  Pol J Microbiol       Date:  2006

10.  Cytotoxin-associated Gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke.

Authors:  Marina Diomedi; Paolo Stanzione; Fabrizio Sallustio; Giorgia Leone; Antonio Renna; Giulia Misaggi; Carla Fontana; Patrizio Pasqualetti; Antonio Pietroiusti
Journal:  Helicobacter       Date:  2008-12       Impact factor: 5.753

View more
  5 in total

1.  Helicobacter pylori seropositivity and its association with incident all-cause and Alzheimer's disease dementia in large national surveys.

Authors:  May A Beydoun; Hind A Beydoun; Martine Elbejjani; Gregory A Dore; Alan B Zonderman
Journal:  Alzheimers Dement       Date:  2018-06-28       Impact factor: 21.566

Review 2.  The Effects of Porphyromonas gingivalis on Atherosclerosis-Related Cells.

Authors:  Jiaqi Zhang; Mengru Xie; Xiaofei Huang; Guangjin Chen; Ying Yin; Xiaofeng Lu; Guangxia Feng; Ran Yu; Lili Chen
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

3.  Association of Helicobacter pylori Infection With Carotid Atherosclerosis in a Northern Chinese Population: A Cross-Sectional Study.

Authors:  Pu Zhang; Qian He; Daiyu Song; Yiying Wang; Xinyue Liu; Guoyong Ding; Weijia Xing
Journal:  Front Cardiovasc Med       Date:  2022-01-31

4.  Helicobacter pylori Infection Impairs Endothelial Function Through an Exosome-Mediated Mechanism.

Authors:  Xiujuan Xia; Linfang Zhang; Jingshu Chi; Huan Li; Xiaoming Liu; Tingzi Hu; Rong Li; Yinjie Guo; Xue Zhang; Hui Wang; Jin Cai; Yixi Li; Da Liu; Yuqi Cui; Xilong Zheng; Gregory C Flaker; Duanfang Liao; Hong Hao; Zhenguo Liu; Canxia Xu
Journal:  J Am Heart Assoc       Date:  2020-03-15       Impact factor: 5.501

5.  Exosome-Transmitted miR-25 Induced by H. pylori Promotes Vascular Endothelial Cell Injury by Targeting KLF2.

Authors:  Na Li; Shi-Feng Liu; Kai Dong; Gui-Chun Zhang; Jing Huang; Zhi-Heng Wang; Tong-Jian Wang
Journal:  Front Cell Infect Microbiol       Date:  2019-10-29       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.